Kinex Pharmaceuticals Secures $300,000 New Funding
- Feed Type
- Link
http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=9ed33f54-130f-4555-9051-5f0b427ad59a - Date
12/23/2013 - Company Name
Kinex Pharmaceuticals - Mailing Address
701 Ellicott Street Buffalo, NY 14203 - Company Description
Kinex is a specialty pharmaceutical company focused on the development and commercialization of next generation therapies for cancer and immunomodulatory diseases. - Website
http://www.kinexpharma.com - Transaction Type
Venture Equity - Transaction Amount
$300,000 - Transaction Round
Undisclosed - Proceeds Purposes
Proceeds purposes were not disclosed. SEC regulatory filing. Contact technology company for solicitation details, if applicable. - M&A Terms
- Venture Investor
Undisclosed
